The October issue of the European Journal of Neurology is online now!
Online access is free-of-charge for EAN members. Please contact headoffice@eaneurology.org, if you Need help with your access token.
European Journal of Neurology was last modified: July 5th, 2016… Continue Reading
Monthly Archives
September 2014
-
-
Top articles 2012 1 = Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.
Waters, PJ; McKeon, A; Leite, MI; et al.
NEUROLOGY Volume: 78 Issue: 9 Pages: 665-671 Published: FEB 2012
Times Cited: 73 (from Web of Science… Continue Reading -
Gian Luigi Lenzi (GLL): As Secretary General to EAN, can you illustrate the role you give to EAN within the community of European Neurologists? Didier Leys (DL): The EAN is a society of both individual members and national societies. This… Continue Reading
-
Grand Rounds
eBrain Sessions of the Month: eBrain modules for new doctors & specialist trainees
September 1, 2014by Hannah Cock The end of the traditional academic year will see thousands of new doctors across Europe start post-graduate medical training in clinical neurosciences, and many more starting to work as new doctors for the first time, so is… Continue Reading -
by Wolfgang Grisold Earlier this year, the first Joint Congress of European Neurology took place in Istanbul. This was the final stage in the process of merging the two European neurological societies — the European Neurological Society (ENS) and… Continue Reading
-
The first paper that I would like to point out to the Neuropenews readers has been published on the prestigious PNAS (Tang-Schomer et al; Proc. Natl. Acad. Sci. U.S.A. 10.1073/pnas.1324214111.(2014), and it is reporting about a model of the six-layer human cortical brain tissue. Biological models as well as computer models (see Lancet Neurology, August 2014) look like very “hot spots” in the neuroscience panorama.
-
Forum
Science from a Tweet: Experimental Ebola drug ZMapp raises big ethical issues, we need to think both ‘carefully & humanistically’
September 1, 2014by Delia Lenzi Two seriously ill volunteers, Kent Brantly and Nancy Writebol, received three monoclonal antibodies, never before administered to humans. Both of them have now complitely recovered. The treatment has generated hope, suspicion, and accusations of inequity. Read more… Continue Reading -
The EAN is a young Society and our purpose is to promote ‘Excellence in Neurology in Europe’. This task has many facets and one of them is to engage more people in the Society. This process is presently underway.
-
All e-learning activities are free-of-charge for EAN members registered to www.eaneurology.org! Answer all questions correctly and you will receive one hour of CME. European Journal of Neurology
Every month one article is chosen for online learning. The following articles are… Continue Reading -
EAN Department-Department Co-operation Programme Application Deadline: November 30, 2014 Since 2001, this training activity is highly appreciated by participants and hosting departments. Each grant is amounting to € 1,500.- plus travel expenses of up to € 300.-. The purpose of… Continue Reading
-
The UEMS EBN examination will be held one day prior to the 1st congress of the European Academy of Neurology in Berlin. http://www.uems-neuroboard.org/ebn/index.php?option=com_wrapper&Itemid=67n Date: Friday, June 19th, 2015 Venue: City Cube Berlin – Messe Berlin GmbH, Messedamm 22, 14055 Berlin,… Continue Reading
-
Report from Dr. Naida Nasrullayeva from Azerbaijan visiting the Department of Neurology at the University Hospital Copenhagen, Denmark under the supervision of Doctor Michael Oettinger. First of all, I would like to thank EFNS (EAN) for the opportunity to visit… Continue Reading
-
EAN News
Impressions of the First Joint Congress of the ENS and EFNS in Istanbul 2014
September 1, 2014Rudolf Martini, Würzburg, Germany, was the first speaker of this session and talked about opportunities for treatment of CMT diseases. At the moment, there is no cure for these genetic neuropathies. Studies (mouse and human) with many substances studied, such as ascorbic acid, progesterone antagonist, curcumin, neurotrophin 3, carried out without success.